Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...
OBSERVER CORPS REPORT – COUNTY COUNCIL – JUNE 30, 2026 The video of the full meeting may be seen at Water Service Rates, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results